IgG glycosylation analysis

Proteomics

Volumn 9, Issue 4, 2009, Pages 882-913

  Huhn, Carolin ^a   Selman, Maurice H J ^a   Ruhaak, L Renee ^a   Deelder, André M ^a   Wuhrer, Manfred ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

antibody; Glycopeptides; Glycoprotein; Mass spectrometry; Post translational modification

Indexed keywords

GLYCAN DERIVATIVE; GLYCOPEPTIDE; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PRONASE; PROTEINASE; SERINE PROTEINASE; TRYPSIN;

AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CHROMATOGRAPHY; ELECTROSPRAY MASS SPECTROMETRY; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OSTEOARTHRITIS; PEPTIDE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; RHEUMATOID ARTHRITIS; SEPARATION TECHNIQUE; SIALYLATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; ENDOPEPTIDASES; FEMALE; GLYCOPEPTIDES; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MALE; MASS SPECTROMETRY; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 61349200094     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800715     Document Type: Review

References (209)

1. Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L. et al., Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985, 316, 452-457
2. Wang, W., Singh, S., Zeng, D. L., King, K., Nema, S., Antibody structure, instability, and formulation. J. Pharm. Sci. 2007, 96, 1-26.
3. Jefferis, R., Glycosylation of recombinant antibody therapeutics. Biotechnol. Prog. 2005, 21, 11-16.
4. Parekh, R., Roitt, I., Isenberg, D., Dwek, R., Rademacher, T., Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J. Exp. Med. 1988, 167, 1731-1736.
5. Yamada, E., Tsukamoto, Y., Sasaki, R., Yagyu, K., Takahashi, N., Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj. J. 1997, 14, 401-405.
6. Shikata, K., Yasuda, T., Takeuchi, F., Konishi, T. et al., Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconj. J. 1998, 15, 683-689.
7. Pekelharing, J. M., Hepp, E., Kamerling, J. P., Gerwig, G. J., Leijnse, B., Alterations in carbohydrate composition of serum
8. IgG from patients with rheumatoid arthritis and from pregnant women. Ann. Rheum. Dis. 1988, 47, 91-95.
9. Rook, G. A. W., Steele, J., Brealey, R., Whyte, A. et al., Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmun. 1991, 4, 779-794.
10. Wuhrer, M., Stam, J. C., van de Geijn, F. E., Koeleman, C. A. et al., Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 2007, 7, 4070-4081.
11. Williams, P. J., Arkwright, P. D., Rudd, P, Scragg, I. G. et al., Short communication: Selective placental transport of maternal IgG to the fetus. Placenta 1995, 1 6, 749-756.
12. van Zeben, D., Rook, G. A., Hazes, J. M., Zwinderman, A. H. et al., Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: Results of a follow-up study. Br. J. Rheumatol. 1994, 33, 36-43.
13. Rademacher, T. W., Williams, P., Dwek, R. A., Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA 1994, 91, 6123-6127.
14. Malhotra, R., Wormald, M. R., Rudd, P. M., Fischer, P. B. et al., Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1995, 1, 237-243.
15. Lastra, G. C., Thompson, S. J., Lemonidis, A. S., Elson, C. J., Changes in the galactose content of IgG during humoral immune responses. Autoimmunity 1998, 28, 25-30.
16. Kaneko, Y., Nimmerjahn, F., Ravetch, J. V., Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006, 313, 670-673.
17. Bond, A., Alavi, A., Axford, J. S., Bourke, B. E. et al.,A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J. Autoimmun. 1997, 10, 77-85.
18. Parekh, R. B., Roitt, I. M., Isenberg, D. A., Dwek, R. A. et al., Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988, 331, 966-969.
19. Parekh, R., Isenberg, D., Rook, G., Roitt, I. et al., A comparative analysis of disease-associated changes in the galactosylation of serum IgG. J. Autoimmun. 1989, 2, 101-114.
20. Bond, A., Alavi, A., Axford, J. S., Youinou, P., Hay, F. C., The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin. Exp. Immunol. 1996, 105, 99-103.
21. Dube, R., Rook, G. A., Steele, J., Brealey, R. et al., Agalactosyl IgG in inflammatory bowel disease: Correlation with Creactive protein. Gut 1990, 31, 431-434.
22. Mehta, A. S., Long, R. E., Comunale, M. A., Wang, M. et al., Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. J. Virol. 2008, 82, 1259-1270.
23. Moore, J. S., Wu, X., Kulhavy, R., Tomana, M. et al., Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS 2005, 19, 381-389.
24. Saldova, R., Royle, L., Radcliffe, C. M., Hamid, U. M. et al., Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007, 17, 1321-1332.
25. Allhorn, M., Olin, A. I., Nimmerjahn, F., Collin, M., Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS ONE 2008, 3, e1413.
26. Collin, M., Shannon, O., Bjorck, L., IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc. Natl. Acad. Sci. USA 2008, 105, 4265-4270.
27. Krapp, S., Mimura, Y., Jefferis, R., Huber, R., Sondermann, P., Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 2003, 325, 979-989.
28. Kanda, Y., Yamada, T., Mori, K., Okazaki, A. et al., Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: The high-mannose, hybrid, and complex types. Glycobiology 2007, 17, 104-118.
29. Mimura, Y., Church, S., Ghirlando, R., Ashton, P. R. et al., The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: Properties of a series of truncated glycoforms. Mol. Immunol. 2000, 37, 697-706.
30. Mimura, Y., Sondermann, P., Ghirlando, R., Lund, J. et al., Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J. Biol. Chem. 2001, 276, 45539-45547.
31. Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y. et al., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 2002, 277, 26733-26740.
32. Iida, S., Misaka, H., Inoue, M., Shibata, M. et al., Non-fucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to Fc gamma RIIIa. Clin. Cancer Res. 2006, 12, 2879-2887.
33. Mori, K., Iida, S., Yamane-Ohnuki, N., Kanda, Y. et al., Non-fucosylated therapeutic antibodies: The next generation of therapeutic antibodies. Cytotechnology 2007, 55, 109-114.
34. Wuhrer, M., Porcelijn, L., Kapur, R., Koeleman, C. A. M. et al., Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J. Proteome Res. 2008, in press.
35. Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N. et al., Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008, 320, 373-376.
36. Nimmerjahn, F., Ravetch, J. V., The antiinflammatory activity of IgG: The intravenous IgG paradox. J. Exp. Med. 2007, 204, 11-15.
37. Katz, U., Achiron, A., Sherer, Y., Shoenfeld, Y., Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun. Rev. 2007, 6, 257-259.
38. Prahl, J. W., Porter, R. R., Allotype-related sequence variation of the heavy chain of rabbit immunoglobulin G. Biochem. J. 1968, 107, 753-763.
39. Watson, M., Rudd, P. M., Bland, M., Dwek, R. A., Axford, J. S., Sugar printing rheumatic diseases: A potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum. 1999, 42, 1682-1690.
40. Kuroda, Y., Shikata, K., Takeuchi, F., Akazawa, T. et al., Structural alterations in outer arms of IgG oligosaccharides in patients with Werner syndrome. Exp. Gerontol. 2007, 42, 545-553.
41. Kuroda, Y., Nakata, M., Makino, A., Matsumoto, A. et al., Structural studies on IgG oligosaccharides of patients with primary Sjögren's syndrome. Glycoconj. J. 2002, 19, 23-31.
42. Lim, A., Reed-Bogan, A., Harmon, B. J., Glycosylation profiling of a therapeutic recombinant monoclonal antibody with two N-linked glycosylation sites using liquid chromatography coupled to a hybrid quadrupole time-of-flight mass spectrometer. Anal. Biochem. 2008, 375, 163-172.
43. Olivova, P., Chen, W., Chakraborty, A. B., Gebler, J. C., Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2008, 22, 29-40.
44. Qian, J., Liu, T., Yang, L., Daus, A., Crowley, R., Zhou, Q., Structural characterization of N-linked oligosaccharides on monoclonal antibody cetuximab by the combination of orthogonal matrix-assisted laser desorption/ionization hybrid quadrupole-quadrupole time-of-flight tandem mass spectrometry and sequential enzymatic digestion. Anal. Biochem. 2007, 364, 8-18.
45. Schuster, M., Jost, W., Mudde, G. C., Wiederkum, S. et al.,In vivo glyco-engineered antibody with improved lytic potential produced by an innovative nonmammalian expression system. Biotechnol. J. 2007, 2, 700-708.
46. Holland, M., Yagi, H., Takahashi, N., Kato, K. et al., Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim. Biophys. Acta 2006, 1760, 669-677.
47. Omtvedt, L. A., Royle, L., Husby, G., Sletten, K. et al., Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum. 2006, 54, 3433-3440.
48. Youings, A., Chang, S. C., Dwek, R. A., Scragg, I. G., Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. Biochem. J. 1996, 314, 621-630.
49. Wada, Y., Azadi, P., Costello, C. E., Dell, A. et al., Comparison of the methods for profiling glycoprotein glycans-HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 2007, 17, 411-422.
50. Mechref, Y., Muzikar, J., Novotny, M. V., Comprehensive assessment of N-glycans derived from a murine monoclonal antibody: A case for multimethodological approach. Electrophoresis 2005, 26, 2034-2046.
51. Huang, L., Biolsi, S., Bales, K. R., Kuchibhotla, U., Impact of variable domain glycosylation on antibody clearance: An LC/MS characterization. Anal. Biochem. 2006, 349, 197-207.
52. Millward, T. A., Heitzmann, M., Bill, K., Langle, U. et al., Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice. Biologicals 2008, 36, 41-47.
53. Stadlmann, J., Pabst, M., Kolarich, D., Kunert, R., Altmann, F., Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics 2008, 8, 2858-2871.
54. Harazono, A., Kawasaki, N., Itoh, S., Hashii, N. et al., Simultaneous glycosylation analysis of human serum glycopro teins by high-performance liquid chromatography/tandem mass spectrometry. J. Chromatogr. B 2008, 869, 20-30.
55. Jacquemin, M., Radcliffe, C. M., Lavend'homme, R., Wormald, M. R. et al., Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody. J. Thromb. Haemost. 2006, 4, 1047-1055.
56. Chen, X., Flynn, G. C., Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase highperformance liquid chromatography/mass spectrometry. Anal. Biochem. 2007, 370, 147-161.
57. Gennaro, L. A., Salas-Solano, O., On-line CE-LIF-MS technology for the direct characterization of N-linked glycans from therapeutic antibodies. Anal. Chem. 2008, 80, 3838-3845.
58. Harvey, D. J., Crispin, M., Scanlan, C., Singer, B. B. et al., Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG. Rapid Commun. Mass Spectrom. 2008, 22, 1047-1052.
59. Hodoniczky, J., Zheng, Y. Z., James, D. C., Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol. Prog. 2005, 21, 1644-1652.
60. Kamoda, S., Nomura, C., Kinoshita, M., Nishiura, S. et al., Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis. J. Chromatogr. A 2004, 1050, 211-216.
61. Kamoda, S., Ishikawa, R., Kakehi, K., Capillary electrophoresis with laser-induced fluorescence detection for detailed studies on N-linked oligosaccharide profile of therapeutic recombinant monoclonal antibodies. J. Chromatogr. A 2006, 1133, 332-339.
62. Kanoh, Y., Mashiko, T., Danbara, M., Takayama, Y. et al., Analysis of the oligosaccharide chain of human serum immunoglobulin G in patients with localized or metastatic cancer. Oncology 2004, 66, 365-370.
63. Leibiger, H., Wustner, D., Stigler, R. D., Marx, U., Variable domain-linked oligosaccharides of a human monoclonal IgG: Structure and influence on antigen binding. Biochem. J. 1999, 338, 529-538.
64. Majid, F. A., Butler, M., Al Rubeai, M., Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: The effect of culture mode and the anti-apoptotic gene, bcl-2. Biotechnol. Bioeng. 2007, 97, 156-169.
65. Fernández, L. E. M., Kalume, D. E., Calvo, L., Fernández, M. M. et al., Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography. J. Chromatogr. B 2001, 752, 247-261.
66. Saba, J. A., Kunkel, J. P., Jan, D. C., Ens, W. E. et al., A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Anal. Biochem. 2002, 305, 16-31.
67. Takegawa, Y., Deguchi, K., Nakagawa, H., Nishimura, S., Structural analysis of an N-glycan with "beta1-4 bisecting branch" from human serum IgG by negative-ion MSn spectral matching and exoglycosidase digestion. Anal. Chem. 2005, 77, 6062-6068.
68. Takegawa, Y., Deguchi, K., Keira, T., Ito, H. et al., Separation of isomeric 2-aminopyridine derivatized N-glycans and N
69. glycopeptides of human serum immunoglobulin G by using a zwitterionic type of hydrophilic-interaction chromatography. J. Chromatogr. A 2006, 1113, 177-181.
70. Yu, Y. Q., Gilar, M., Kaska, J., Gebler, J. C., A rapid sample preparation method for mass spectrometric characterization of N-linked glycans. Rapid Commun. Mass Spectrom. 2005, 19, 2331-2336.
71. Homma, H., Tozawa, K., Yasui, T., Itoh, Y. et al., Abnormal glycosylation of serum IgG in patients with IgA nephropathy. Clin. Exp. Nephrol. 2006, 10, 180-185.
72. Mimura, Y., Ashton, P. R., Takahashi, N., Harvey, D. J., Jefferis, R., Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J. Immunol. Methods 2007, 326,116-126.
73. Rouwendal, G. J., Wuhrer, M., Florack, D. E., Koeleman, C. A. et al., Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N- acetylglucosaminyltransferase III. Glycobiology 2007, 17, 334-344.
74. Yamaguchi, Y., Nishimura, M., Nagano, M., Yagi, H. et al., Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim. Biophys. Acta 2006, 1760, 693-700.
75. Takahashi, N., Ishii, I., Ishihara, H., Mori, M. et al., Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry 1987, 26, 1137-1144.
76. Takegawa, Y., Deguchi, K., Ito, S., Yoshioka, S. et al., Simultaneous analysis of 2-aminopyridine-derivatized neutral and sialylated oligosaccharides from human serum in the negative-ion mode by sonic spray ionization ion trap mass spectrometry. Anal. Chem. 2005, 77, 2097-2106.
77. Kunkel, J. P., Jan, D. C., Butler, M., Jamieson, J. C., Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors. Biotechnol. Prog. 2000, 16, 462-470.
78. Taniguchi, T., Mizuochi, T., Beale, M., Dwek, R. A. et al., Structures of the sugar chains of rabbit immunoglobulin G: Occurrence of asparagine-linked sugar chains in Fab fragment. Biochemistry 1985, 24, 5551-5557.
79. Harada, H., Kamei, M., Tokumoto, Y., Yui, S. et al., Systematic fractionation of oligosaccharides of human immunoglobulin G by serial affinity chromatography on immobilized lectin columns. Anal. Biochem. 1987, 164, 374-381.
80. Packer, N. H., Lawson, M. A., Jardine, D. R., Redmond, J. W., A general approach to desalting oligosaccharides released from glycoproteins. Glycoconj. J. 1998, 15, 737-747.
81. Yuen, C. T., Gee, C. K., Jones, C., High-performance liquid chromatographic profiling of fluorescent labelled N-glycans on glycoproteins. Biomed. Chromatogr. 2002, 16, 247-254.
82. Papac, D. I., Briggs, J. B., Chin, E. T., Jones, A. J., A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis. Glycobiology 1998, 8, 445-454.
83. Royle, L., Campbell, M. P., Radcliffe, C. M., White, D. M. et al., HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal. Biochem. 2008, 376, 1-12.
84. Laroy, W., Contreras, R., Callewaert, N., Glycome mapping on DNA sequencing equipment. Nat. Protoc. 2006, 1, 397-405.
85. Shilova, N. V., Bovin, N. V., Fluorescent labels for analysis of mono- and oligosaccharides. Russ. J. Bioorg. Chem. 2003, 29, 309-324.
86. Anumula, K. R., Advances in fluorescence derivatization methods for high-performance liquid chromatographic analysis of glycoprotein carbohydrates. Anal. Biochem. 2006, 350, 1-23.
87. Kamoda, S., Nakano, M., Ishikawa, R., Suzuki, S., Kakehi, K., Rapid and sensitive screening of N-glycans as 9-fluorenylmethyl derivatives by high-performance liquid chromatography: A method which can recover free oligosaccharides after analysis. J. Proteome Res. 2005, 4, 146-152.
88. Bigge, J. C., Patel, T. P., Bruce, J. A., Goulding, P. N. et al., Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 1995, 230, 229-238.
89. Anumula, K. R., Quantitative determination of monosaccharides in glycoproteins by high-performance liquid chromatography with highly sensitive fluorescence detection. Anal. Biochem. 1994, 220, 275-283.
90. Takegawa, Y., Deguchi, K., Ito, H., Keira, T. et al., Simple separation of isomeric sialylated N-glycopeptides by a zwitterionic type of hydrophilic interaction chromatography. J. Sep. Sci. 2006, 29, 2533-2540.
91. Domann, P. J., Pardos-Pardos, A. C., Fernandes, D. L., Spencer, D. I. et al., Separation-based glycoprofiling approaches using fluorescent labels. Proteomics 2007, 7, 70-76.
92. Wormald, M. R., Rudd, P. M., Harvey, D. J., Chang, S. C. et al., Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 1997, 36, 1370-1380.
93. Guile, G. R., Rudd, P. M., Wing, D. R., Prime, S. B., Dwek, R. A., A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 1996, 240, 210-226.
94. Ruhaak, L. R., Huhn, C., Waterreus, W. J., de Boer, A. R. et al., Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins. Anal. Chem. 2008, 80, 6119-6126.
95. Prater, B. D., Anumula, K. R., Hutchins, J. T., Automated sample preparation facilitated by PhyNexus MEA purification system for oligosaccharide mapping of glycoproteins. Anal. Biochem. 2007, 369, 202-209.
96. Kamoda, S., Kakehi, K., Evaluation of glycosylation for quality assurance of antibody pharmaceuticals by capillary electrophoresis. Electrophoresis 2008, 29, 3595-3604.
97. Zhuang, Z., Starkey, J. A., Mechref, Y., Novotny, M. V., Jacobson, S. C., Electrophoretic analysis of N-glycans on microfluidic devices. Anal. Chem. 2007, 79, 7170-7175.
98. Callewaert, N., Contreras, R., Mitnik-Gankin, L., Carey, L. et al., Total serum protein N-glycome profiling on a capillary electrophoresis-microfluidics platform. Electrophoresis 2004, 25, 3128-3131.
99. Pabst, M., Bondili, J. S., Stadlmann, J., Mach, L., Altmann, F., Mass + retention time = structure: A strategy for the analy
100. sis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal. Chem. 2007, 79, 5051-5057.
101. Kang, P., Mechref, Y., Kyselova, Z., Goetz, J. A., Novotny, M. V., Comparative glycomic mapping through quantitative permethylation and stable-isotope labeling. Anal. Chem. 2007, 79, 6064-6073.
102. Atwood, J. A. III, Cheng, L., Alvarez-Manilla, G., Warren, N. L. et al., Quantitation by isobaric labeling: Applications to glycomics. J. Proteome Res. 2008, 7, 367-374.
103. Prien, J. M., Huysentruyt, L. C., Ashline, D. J., Lapadula, A. J. et al., Differentiating N-linked glycan structural isomers in metastatic and nonmetastatic tumor cells using sequential mass spectrometry. Glycobiology 2008, 18, 353-366.
104. Ashline, D. J., Lapadula, A. J., Liu, Y. H., Lin, M. et al., Carbohydrate structural isomers analyzed by sequential mass spectrometry. Anal. Chem. 2007, 79, 3830-3842.
105. Costello, C. E., Contado-Miller, J. M., Cipollo, J. F., A glycomics platform for the analysis of permethylated oligo-saccharide alditols. J. Am. Soc. Mass Spectrom. 2007, 18, 1799-1812.
106. Kang, P., Mechref, Y., Novotny, M. V., High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun. Mass Spectrom. 2008, 22, 721-734.
107. Zhang, Y., Go, E. P., Desaire, H., Maximizing coverage of glycosylation heterogeneity in MALDI-MS analysis of glycoproteins with up to 27 glycosylation sites. Anal. Chem. 2008, 80, 3144-3158.
108. Schähs, M., Strasser, R., Stadlmann, J., Kunert, R. et al., Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol. J. 2007, 5, 657-663.
109. Yu, Y. Q., Fournier, J., Gilar, M., Gebler, J. C., Identification of N-linked glycosylation sites using glycoprotein digestion with pronase prior to MALDI tandem time-of-flight mass spectrometry. Anal. Chem. 2007, 79, 1731-1738.
110. Hirayama, K., Yuji, R., Yamada, N., Kato, K. et al., Complete and rapid peptide and glycopeptide mapping of mouse monoclonal antibody by LC/MS/MS using ion trap mass spectrometry. Anal. Chem. 1998, 70, 2718-2725.
111. Rehder, D. S., Dillon, T. M., Pipes, G. D., Bondarenko, P. V., Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics. J. Chromatogr. A 2006, 1102, 164-175.
112. Bongers, J., Cummings, J. J., Ebert, M. B., Federici, M. M. et al., Validation of a peptide mapping method for a therapeutic monoclonal antibody: What could we possibly learn about a method we have run 100 times? J. Pharm. Biomed. Anal. 2000, 21, 1099-1128.
113. Janecki, D. J., Broshears, W. C., Reilly, J. P., Photoimmobilization of proteins for affinity capture combined with MALDI TOF MS analysis. Anal. Chem. 2004, 76, 6643-6650.
114. Jmeian, Y., El Rassi, Z., Tandem affinity monolithic microcolumns with immobilized protein A, protein G', and antibodies for depletion of high abundance proteins from serum samples: Integrated microcolumn-based fluidic system for simultaneous depletion and tryptic digestion. J. Proteome Res. 2007, 6, 947-954.
115. Korecka, L., Bilkova, Z., Holeapek, M., Kralovsky, J. et al., Utilization of newly developed immobilized enzyme reac tors for preparation and study of immunoglobulin G fragments. J. Chromatogr. B 2004, 808, 15-24.
116. Stigter, E. C., de Jong, G. J., van Bennekom, W. P., Development of an open-tubular trypsin reactor for on-line digestion of proteins. Anal. Bioanal. Chem. 2007, 389, 1967-1977.
117. Stigter, E. C., de Jong, G. J., van Bennekom, W. P., Pepsin immobilized in dextran-modified fused-silica capillaries for on-line protein digestion and peptide mapping. Anal. Chim. Acta 2008, 619, 231-238.
118. Ito, H., Takegawa, Y., Deguchi, K., Nagai, S. et al., Direct structural assignment of neutral and sialylated N-glycans of glycopeptides using collision-induced dissociation MSn spectral matching. Rapid Commun. Mass Spectrom. 2006, 20, 3557-3565.
119. Suzuki, N., Lee, Y. C., Site-specific N-glycosylation of chicken serum IgG. Glycobiology 2004, 14, 275-292.
120. Wada, Y., Tajiri, M., Yoshida, S., Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. Anal. Chem. 2004, 76, 6560-6565.
121. Weitzman, S., Portmore, J., Immunoglobulin glycopeptides from an IgG2b-producing mouse myeloma cell line and from variant cell lines. J. Immunol. 1981, 127, 2095-2101.
122. Strader, M. B., Tabb, D. L., Hervey, W. J., Pan, C., Hurst, G. B., Efficient and specific trypsin digestion of microgram to nanogram quantities of proteins in organic-aqueous solvent systems. Anal. Chem. 2006, 78, 125-134.
123. Hervey, W. J., Strader, M. B., Hurst, G. B., Comparison of digestion protocols for microgram quantities of enriched protein samples. J. Proteome Res. 2007, 6, 3054-3061.
124. Rousseaux, J., Rousseaux-Prevost, R., Bazin, H., Isolation and characterization of a VH domain fragment from monoclonal rat IgG of IgG1 and IgG2a subclasses. Mol. Immunol. 1989, 26, 27-32.
125. Suzuki, N., Khoo, K. H., Chen, C. M., Chen, H. C., Lee, Y. C., N-glycan structures of pigeon IgG: A major serum glycoprotein containing Galalpha1-4 Gal termini. J. Biol. Chem. 2003, 278, 46293-46306.
126. Scherer, H. U., Wang, J., Toes, R. E. M., van der Woude, D. et al., Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum. Prot. Clin. Appl. 2009, 3, 106-115.
127. Kim, H., Yamaguchi, Y., Masuda, K., Matsunaga, C. et al.,O-glycosylation in hinge region of mouse immunoglobulin G2b. J. Biol. Chem. 1994, 269, 12345-12350.
128. Sheeley, D. M., Merrill, B. M., Taylor, L. C., Characterization of monoclonal antibody glycosylation: Comparison of expression systems and identification of terminal alpha-linked galactose. Anal. Biochem. 1997, 247, 102-110.
129. Beck, A., Bussat, M. C., Zorn, N., Robillard, V. et al., Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. J. Chromatogr. B 2005, 819, 203-218.
130. Rousseaux, J., Rousseaux-Prevost, R., Bazin, H., Biserte, G., Proteolysis of rat IgG subclasses by Staphylococcus aureus V8 proteinase. Biochim. Biophys. Acta 1983, 748, 205-212.
131. Prokesova, L., Potuznikova, B., Potempa, J., Zikan, J. et al., Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aureus. Immunol. Lett. 1992, 31, 259-265.
132. Martens, L., Immunomics: Entwicklung einer ESI-MS basierten methodik zurdifferenzierung und quantifizierung von humanen immunglobulinen und ihrer glykosylierung. PhD Thesis, Koeln, 2003, pp. 1-185. http://kups.ub.uni- koeln.de/volltexte/2004/1056/pdf/Dissertation-Lejon-Martens2.pdf.
133. An, H. J., Peavy, T. R., Hedrick, J. L., Lebrilla, C. B., Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal. Chem. 2003, 75, 5628-5637.
134. Temporini, C., Perani, E., Calleri, E., Dolcini, L. et al., Pronase-immobilized enzyme reactor: An approach for automation in glycoprotein analysis by LC/LC-ESI/MSn. Anal. Chem. 2007, 79, 355-363.
135. Wuhrer, M., Koeleman, C. A., Hokke, C. H., Deelder, A. M., Protein glycosylation analyzed by normal-phase nanoliquid chromatography-mass spectrometry of glycopeptides. Anal. Chem. 2005, 77, 886-894.
136. Clowers, B. H., Dodds, E. D., Seipert, R. R., Lebrilla, C. B., Site determination of protein glycosylation based on digestion with immobilized nonspecific proteases and Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 2007, 6, 4032-4040.
137. Rothman, R. J., Warren, L., Vliegenthart, J. F., Hard, K. J., Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas. Biochemistry 1989, 28, 1377-1384.
138. Tai, T., Ito, S., Yamashita, K., Muramatsu, T., Kobata, A., Asparagine-linked oligosaccharide chains of IgG: A revised structure. Biochem. Biophys. Res. Commun. 1975, 65, 968-974.
139. Cheron, A., Fournet, B., Spik, G., Montreuil, J., Complete structure of glycopeptides isolated from IgG immunoglobulins of cow colostrum. Biochimie 1976, 58, 927-942.
140. Lee, S. O., Connolly, J. M., Ramirez-Soto, D., Poretz, R. D., The polypeptide of immunoglobulin G influences its galactosylation in vivo. J. Biol. Chem. 1990, 265, 5833-5839.
141. Kroon, D. J., Freedy, J., Burinsky, D. J., Sharma, B., Rapid profiling of carbohydrate glycoforms in monoclonal antibodies using MALDI/TOF mass spectrometry. J. Pharm. Biomed. Anal. 1995, 13, 1049-1054.
142. Perdivara, I., Deterding, L., Moise, A., Tomer, K. B., Przybylski, M., Determination of primary structure and microheterogeneity of a beta-amyloid plaque-specific antibody using high-performance LC-tandem mass spectrometry. Anal. Bioanal. Chem. 2008, 391, 325-336.
143. Wagner-Rousset, E., Bednarczyk, A., Bussat, M. C., Colas, O. et al., The way forward, enhanced characterization of therapeutic antibody glycosylation: Comparison of three level mass spectrometry-based strategies. J. Chromatogr. B 2008, 872, 23-37.
144. Huang, L., Lu, J., Wroblewski, V. J., Beals, J. M., Riggin, R. M., In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. Anal. Chem. 2005, 77, 1432-1439.
145. Chakraborty, A. B., Berger, S. J., Optimization of reversedphase peptide liquid chromatography ultraviolet mass spectrometry analyses using an automated blending methodology. J. Biomol. Tech. 2005, 16, 327-335.
146. Shou, W. Z., Naidong, W., Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds. J. Chromatogr. B 2005, 825, 186-192.
147. Huddleston, M. J., Bean, M. F., Carr, S. A., Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: Methods for selective detection of glycopeptides in protein digests. Anal. Chem. 1993, 65, 877-884.
148. Kilgore, B. R., Lucka, A. W., Patel, R., Andrien, B. A., Jr., Dhume, S. T., Comparability and monitoring immunogenic N-linked oligosaccharides from recombinant monoclonal antibodies from two different cell lines using HPLC with fluorescence detection and mass spectrometry. Methods Mol. Biol. 2008, 446, 333-346.
149. Karnoup, A. S., Kuppannan, K., Young, S. A., A novel HPLC-UV-MS method for quantitative analysis of protein glycosylation. J. Chromatogr. B 2007, 859, 178-191.
150. Boersema, P. J., Mohammed, S., Heck, A. J., Hydrophilic interaction liquid chromatography (HILIC) in proteomics. Anal. Bioanal. Chem. 2008, 391, 151-159.
151. Zhang, B., Yang, Y., Yuk, I., Pai, R. et al., Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody. Anal. Chem. 2008, 80, 2379-2390.
152. Jiskoot, W., van de, W. G., Martin, J. M., Green, B. N. et al., Application of electrospray mass spectrometry (ES-MS) for the analysis of monoclonal antibody Fc subunits. Pharm. Res. 1992, 9, 945-951.
153. Battersby, J. E., Snedecor, B., Chen, C., Champion, K. M. et al., Affinity-reversed-phase liquid chromatography assay to quantitate recombinant antibodies and antibody fragments in fermentation broth. J. Chromatogr. A 2001, 927, 61-76.
154. Ryan, M. H., Petrone, D., Nemeth, J. F., Barnathan, E. et al., Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol. Immunol. 2008, 45, 1837-1846.
155. Adamczyk, M., Gebler, J. C., Wu, J., Papain digestion of different mouse IgG subclasses as studied by electrospray mass spectrometry. J. Immunol. Methods 2000, 237,95-104.
156. Ashton, D. S., Beddell, C. R., Cooper, D. J., Craig, S. J. et al., Mass spectrometry of the humanized monoclonal antibody CAMPATH 1H. Anal. Chem. 1995, 67, 835-842.
157. Hagmann, M. L., Kionka, C., Schreiner, M., Schwer, C., Characterization of the F(ab')2 fragment of a murine monoclonal antibody using capillary isoelectric focusing and electrospray ionization mass spectrometry. J. Chromatogr. A 1998, 816, 49-58.
158. Kelly, L. S., Kozak, M., Walker, T., Pierce, M., Puett, D., Lectin immunoassays using antibody fragments to detect glycoforms of human chorionic gonadotropin secreted by choriocarcinoma cells. Anal. Biochem. 2005, 338, 253-262.
159. Moorhouse, K. G., Nashabeh, W., Deveney, J., Bjork, N. S. et al., Validation of an HPLC method for the analysis of the charge heterogeneity of the recombinant monoclonal anti body IDEC-C2B8 after papain digestion. J. Pharm. Biomed. Anal. 1997, 16, 593-603.
160. Masuda, K., Yamaguchi, Y., Kato, K., Takahashi, N. et al., Pairing of oligosaccharides in the Fc region of immunoglobulin G. FEBS Lett.
161. Santora, L. C., Krull, I. S., Grant, K., Characterization of recombinant human monoclonal tissue necrosis factoralpha antibody using cation-exchange HPLC and capillary isoelectric focusing. Anal. Biochem. 1999, 275, 98-108.
162. von Pawel-Rammingen, U., Johansson, B. P., Bjorck, L., IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 2002, 21, 1607-1615.
163. Ren, D., Pipes, G., Xiao, G., Kleemann, G. R. et al., Reversed-phase liquid chromatography-mass spectrometry of site-specific chemical modifications in intact immunoglobulin molecules and their fragments. J. Chromatogr. A 2008, 1179, 198-204.
164. Gadgil, H. S., Bondarenko, P. V., Pipes, G. D., Dillon, T. M. et al., Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody sing Lys-C limited proteolysis coupled with LC/MS analysis. Anal. Biochem. 2006, 355, 165-174.
165. Liu, H., Gaza-Bulseco, G., Chumsae, C., Radziejewski, C. H., Mass spectrometry analysis of in vitro nitration of a recombinant human IgG1 monoclonal antibody. Rapid Commun. Mass Spectrom. 2008, 22, 1-10.
166. Martinez, T., Pace, D., Brady, L., Gerhart, M., Balland, A., Characterization of a novel modification on IgG2 light chain. Evidence for the presence of O-linked mannosylation. J. Chromatogr. A 2007, 1156, 183-187.
167. Wan, H. Z., Kaneshiro, S., Frenz, J., Cacia, J., Rapid method for monitoring galactosylation levels during recombinant antibody production by electrospray mass spectrometry with selective-ion monitoring. J. Chromatogr. A 2001, 913, 437-446.
168. Brady, L. J., Valliere-Douglass, J., Martinez, T., Balland, A., Molecular mass analysis of antibodies by on-line SEC-MS. J. Am. Soc. Mass Spectrom. 2008, 19, 502-509.
169. Küster, B., Wheeler, S. F., Hunter, A. P., Dwek, R. A., Harvey, D. J., Sequencing of N-linked oligosaccharides directly from protein gels: In-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal. Biochem. 1997, 250, 82-101.
170. Yamaguchi, Y., Kim, H., Kato, K., Masuda, K. et al., Proteolytic fragmentation with high specificity of mouse immunoglobulin G. Mapping of proteolytic cleavage sites in the hinge region. J. Immunol. Methods 1995, 181, 259-267.
171. Mariani, M., Camagna, M., Tarditi, L., Seccamani, E., A new enzymatic method to obtain high-yield F(ab)2 suitable for clinical use from mouse IgGl 1. Mol. Immunol. 1991, 28,69-77.
172. Hunt, G., Nashabeh, W., Capillary electrophoresis sodium dodecyl sulfate nongel sieving analysis of a therapeutic recombinant monoclonal antibody: A biotechnology perspective. Anal. Chem. 1999, 71, 2390-2397.
173. Lausch, R., Scheper, T., Reif, O-W., Schlösser, J. et al., Rapid capillary gel electrophoresis of proteins. J. Chromatogr. A 1993, 654, 190-195.
174. Yasukawa, Z., Sato, C., Sano, K., Ogawa, H., Kitajima, K., Identification of disialic acid-containing glycoproteins in mouse serum: A novel modification of immunoglobulin light chains, vitronectin, and plasminogen. Glycobiology 2006, 16, 651-665.
175. Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J. et al., Identification of multiple sources of charge heterogeneity in a recombinant antibody. J. Chromatogr. B 2001, 752, 233-245.
176. Dillon, T. M., Bondarenko, P. V., Speed, R. M., Development of an analytical reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry method for characterization of recombinant antibodies. J. Chromatogr. A 2004, 1053, 299-305.
177. Perkins, M., Theiler, R., Lunte, S., Jeschke, M., Determination of the origin of charge heterogeneity in a murine monoclonal antibody. Pharm. Res. 2000, 17, 1110-1117.
178. Tang, S., Nesta, D. P., Maneri, L. R., Anumula, K. R., A method for routine analysis of recombinant immunoglobulins (rIgGs) by capillary isoelectric focusing (cIEF). J. Pharm. Biomed. Anal. 1999, 19, 569-583.
179. Kelly, J. A., Lee, C. S., On-line post-capillary affinity detection of immunoglobulin G subclasses and monoclonal antibody variants for capillary electrophoresis. J. Chromatogr. A 1997, 790, 207-214.
180. Armenta, J. M., Gu, B., Humble, P. H., Thulin, C. D., Lee, M. L., Design and evaluation of a coupled monolithic preconcentrator-capillary zone electrophoresis system for the extraction of immunoglobulin G from human serum. J. Chromatogr. A 2005, 1097, 171-178.
181. Dillon, T. M., Bondarenko, P. V., Rehder, D. S., Pipes, G. D. et al., Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability. J. Chromatogr. A 2006, 1120, 112-120.
182. Lattova, E., Chen, V. C., Varma, S., Bezabeh, T., Perreault, H., Matrix-assisted laser desorption/ionization on-target method for the investigation of oligosaccharides and glycosylation sites in glycopeptides and glycoproteins. Rapid Commun. Mass Spectrom. 2007, 21, 1644-1650.
183. Roberts, G. D., Johnson, W. P., Burman, S., Anumula, K. R., Carr, S. A., An integrated strategy for structural characterization of the protein and carbohydrate components of monoclonal antibodies: Application to anti-respiratory syncytial virus MAb. Anal. Chem. 1995, 67, 3613-3625.
184. Masuda, K., Yamaguchi, Y., Kato, K., Kim, H. H. et al., Post-translational modifications of immunoglobulin G: A mouse IgG variant that lacks the entire CH1 domain. Mol. Immunol. 1999, 36, 993-1003.
185. Ahrer, K., Jungbauer, A., Chromatographic and electrophoretic characterization of protein variants. J. Chromatogr. B Biomed. Sci. Appl. 2006, 841, 110-122.
186. Gadgil, H. S., Bondarenko, P. V., Pipes, G., Rehmer, D. et al., The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. J. Pharm. Sci. 2007, 96, 2607-2621.
187. Görg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
188. Dolník, V., Capillary electrophoresis of proteins 2003-2005. Electrophoresis 2005, 27, 126-141.
189. Mechref, Y., Novotny, M. V., Structural investigations of glycoconjugates at high sensitivity. Chem. Rev. 2002, 102, 321-369.
190. Kilár, F., Recent applications of capillary isoelectric focusing. Electrophoresis 2003, 24, 3908-3916.
191. Tran, A. D., Park, S., Lisi, P. J., Huynh, O. T. et al., Separation of carbohydrate-mediated microheterogeneity of recombinant human erythropoietin by free solution capillary electrophoresis: Effects of pH, buffer type and organic additives. J. Chromatogr. A 1991, 542, 459-471.
192. Watson, E., Yao, F., Capillary electrophoretic separation of human recombinant erythropoietin (r-HuEPO) glycoforms. Anal. Biochem. 1993, 210, 389-393.
193. Sanz-Nebot, V., Balaguer, E., Benavente, F., Neusüß, C., Barbosa, J., Characterization of transferrin glycoforms in human serum by CE-UV and CE-ESI-MS. Electrophoresis 2006, 28, 1949-1957.
194. Balaguer, E., Demelbauer, U., Pelzing, M., Sanz-Nebot, V., Neusüß, C., Glycoform characterization of erythropoietin combining glycan and intact protein analysis by capillary electrophoresis - electrospray-time-of-flight mass spectrometry. Electrophoresis 2006, 27, 2638-2650.
195. Balaguer, E., Neusüß, C., Glycoprotein characterization combining intact protein and glycan analysis by capillary electrophoresis- electrospray ionization-mass spectrometry. Anal. Chem. 2006, 78, 5384-5393.
196. Madera, M., Mechref, Y., Novotny, M. V., Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. Anal. Chem. 2005, 77, 4081-4090.
197. Madera, M., Mechref, Y., Klouckova, I., Novotny, M. V., Semiautomated high-sensitivity profiling of human blood serum glycoproteins through lectin preconcentration and multidimensional chromatography/tandem mass spectrometry. J. Proteome Res. 2006, 5, 2348-2363.
198. Gadgil, H. S., Pipes, G. D., Dillon, T. M., Treuheit, M. J., Bondarenko, P. V., Improving mass accuracy of high performance liquid chromatography/ electrospray ionization time-of-flight mass spectrometry of intact antibodies. J. Am. Soc. Mass Spectrom. 2006, 17, 867-872.
199. Geyer, H., Geyer, R., Strategies for analysis of glycoprotein glycosylation. Biochim. Biophys. Acta 2006, 1764, 1853-1869.
200. Yasukawa, Z., Sato, C., Kitajima, K., Inflammation-dependent changes in a-2,3-, a2,6- and a2,8-salic acid glycotopes on serum glycoproteins in mice. Glycobiology 2005, 15, 827-837.
201. Squier, T. C., Bigelow, D. J., Protein oxidation and age-dependent alterations in calcium homeostasis. Front Biosci. 2000, 5, D504-D526.
202. Davies, M. J., The oxidative environment and protein damage. Biochim. Biophys. Acta 2005, 1703, 93-109.
203. Lapolla, A., Fedele, D., Aronica, R., Garbeglio, M. et al., Evaluation of IgG glycation levels by matrix-assisted laser desorption/ ionization mass spectrometry. Rapid Commun. Mass Spectrom. 1997, 11, 1342-1346.
204. Umana, P., Jean-Mairet, J., Moudry, R., Amstutz, H., Bailey, J. E., Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat. Biotechnol. 1999, 17, 176-180.
205. Cox, K. M., Sterling, J. D., Regan, J. T., Gasdaska, J. R. et al., Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat. Biotechnol. 2006, 24, 1591-1597.
206. Bakker, H., Rouwendal, G. J., Karnoup, A. S., Florack, D. E. et al., An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc. Natl. Acad. Sci. USA 2006, 103, 7577-7582.
207. Hamilton, S. R., Gerngross, T. U., Glycosylation engineering in yeast: The advent of fully humanized yeast. Curr. Opin. Biotechnol. 2007, 18, 387-392.
208. Li, H., Sethuraman, N., Stadheim, T. A., Zha, D. et al., Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nat. Biotechnol. 2006, 24, 210-215.
209. Chung, C. H., Mirakhur, B., Chan, E., Le, Q. T. et al., Cetuximab-induced anaphylaxis and IgE specific for galactosealpha-1,3-galactose. N. Engl. J. Med. 2008, 358, 1109-1117.